🔎 Trials Near Me

Hjem › Metastatisk kreft › Michigan › Grand Rapids

Kliniske studier for Metastatisk kreft i Grand Rapids, MI

22 studier for Metastatisk kreft søker deltakere på steder i og rundt Grand Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RekruttererFase 2
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Alle aldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • South Texas Accelerated Research Therapeutics (START), Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RekruttererFase 1
  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

RekruttererFase 1
  • ALX Center 3, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07085091

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

RekruttererFase 2/3
  • The Cancer and Hematology Centers, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

RekruttererFase 3
  • The Cancer & Hematology Centers, Grand Rapids
  • The Cancer & Hematology Centers, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RekruttererFase 1
  • BAMF Health Inc., Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07114601

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RekruttererFase 1/2
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

RekruttererFase 1/2
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05267626

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Clinical Study Site, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • The Cancer & Hematology Centers, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

RekruttererFase 1/2
  • South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07213830

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07029399

A Study of MGC026 in Participants With Advanced Solid Tumors

RekruttererFase 1
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

RekruttererFase 1
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06880549

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RekruttererFase 1/2
  • Crinetics Study Site, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07129252

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RekruttererFase 1
  • Context Investigational Site, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06756035

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

RekruttererFase 1
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT07094204

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

RekruttererFase 1/2
  • Start Midwest Cancer Research, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 28. apr. 2026 · NCT06413680

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

RekruttererObservasjonsstudie
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
2 Months · Alle kjønn · Oppdatert 5. mar. 2026 · NCT02474160

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257

Metastatisk kreft-studier i andre byer

Andre studier i Grand Rapids

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.